(NASDAQ: IRMD) Iradimed's forecast annual revenue growth rate of 6.37% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 118.05%.
Iradimed's revenue in 2025 is $77,635,163.On average, 1 Wall Street analysts forecast IRMD's revenue for 2025 to be $1,050,417,765, with the lowest IRMD revenue forecast at $1,050,417,765, and the highest IRMD revenue forecast at $1,050,417,765.
In 2026, IRMD is forecast to generate $1,148,997,781 in revenue, with the lowest revenue forecast at $1,148,997,781 and the highest revenue forecast at $1,148,997,781.